Skip to main content
May 26, 2022
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
ADC
Ovarian Cancer Treatment
The Antibody Drug Conjugate Mirvetuximab soravtansine appears promising for treatment of certain patients with ovarian cancer.
By Dr. C.H. Weaver M.D.
Mar 24, 2022
CLOSE
CLOSE
CLOSE
CLOSE